Qualifications

Super Specializations: DM (Medical Oncology) from AIIMS
Training: SR Medical Oncology from AIIMS
Post Graduation: MD (Medicine) from AIIMS
Graduation: MBBS from Osmania Medical College

Experience

Field of Expertise

Expertise in managing various types of cancers including blood cancers
Expert in providing the latest cutting edge medications such as Immunotherapy, targeted therapy, bone marrow transplant
Special interest in preventive oncology and role of genetics in cancer

Research & Publications

Chellapuram Santosh Kumar, Srujana Joga, Bivas Biswas, Deepak Dabkara, Kuruswamy Thurai Prasad, Navneet Singh, Prabhat Singh Malik, Sachin Khurana, Sandip Ganguly, Valliappan Muthu, Ullas Batra,Immune checkpoint inhibitors in advanced non–small cell lung cancer: A metacentric experience from India,Current Problems in Cancer, Volume 44, Issue 3, 2020
Chellapuram Santosh Kumar, Lalit & Pramanik, Raja & Sharma, Aparna & Sharma, Atul & Sahoo, Ranjit & Malik, Prabhat & Cyriac, Sunu. (2019). POEMS SYNDROME: A single center study of 68 patients and comparison of consolidation Autologous stem cell transplant(ASCT) versus non-ASCT cohorts.. Clinical Lymphoma Myeloma and Leukemia. 19. e307-e308. 10.1016/j.clml.2019.09.505.
Chellapuram Santosh Kumar, Malik Prabhat S, Kumar Lalit Containing coronavirus (COVID-19) spread in an oncology day care facility in India.IJMPO.Year : 2020 | Volume: 41 | Issue Number: 4 | Page: 468-470
Chellapuram Santosh Kumar, Gogia Ajay Systemic therapy for breast cancer during SARS-CoV-2 pandemic.CRST:Year : 2020 | Volume: 3 | Issue Number: 5 | Page: 35-39
Chellapuram Santosh Kumar & Gogia, Ajay. (2020). Authors’ reply to D’Souza et al.. Cancer Research, Statistics, and Treatment. 3. 334. 10.4103/CRST.CRST_189_20.
Chellapuram Santosh Kumar, Sharma S K :Dengue virus infection: Editorial, NMJI, Year : 2016 | Volume: 29 | Issue Number: 2 | Page: 61-63
Kumar, Lalit & Chellapuram Santosh Kumar & Sahoo, Ranjit & Gupta, Ritu. (2019). VRd versus VCd as induction therapy for newly diagnosed multiple myeloma: A Phase III, randomized study. Clinical Lymphoma Myeloma and Leukemia. 19. e361. 10.1016/j.clml.2019.09.597.
Gogia, A., Kumar, S., Chellapuram Santosh Kumar. et al. Primary Mediastinal B Cell Lymphoma: A Limited Institutional Experience with Uniform DAEPOCH-R Protocol. Indian J Hematol Blood Transfus (2020). https://doi.org/10.1007/s12288-020-01301-z
Gundu Naresh, Lalit Kumar, Atul Sharma, Chellapuram Santosh Kumar, Prabhat Singh Malik, Ranjeet Kumar Sahoo, Raja Pramanik, Ahitagni Biswas .An Experience of Primary Amyloidosis from an Indian Tertiary Cancer Centre: A Retrospective Study.https://doi.org/10.1016/j.clml.2019.07.330
Sharma A, Ganguly S, Chellapuram Santosh Kumar, et al Addition of aprepitant improves acute emesis control in children and adolescents receiving induction chemotherapy for acute myeloid leukemia: a randomized, open-label trial BMJ Supportive & Palliative Care Published Online First: 29 October 2020. doi: 10.1136/bmjspcare-2020-002595
Kumar, Lalit & Chellapuram Santosh Kumar & Mookerjee, Anjali & Sahoo, Ranjit & Malik, Prabhat & Gupta, Ritu & Sharma, Om & Biswas, Ahitagni. (2019). Characteristics and Outcome of Relapsed Myeloma after Single Autologous Stem Cell Transplant: 20-year Experience. Clinical Lymphoma Myeloma and Leukemia. 19. e210-e211. 10.1016/j.clml.2019.09.350.
Kumar, Lalit & Chellapuram Santosh Kumar & Dev, Ramavat & Varshneya, Ankur & Pawar, Satyajit & Sharma, Aparna & Mookerjee, Anjali & Sahoo, Ranjit & Malik, Prabhat & Sharma, Atul & Gupta, Ritu & Sharma, Omdutta & Biswas, Ahitagni & Kumar, Rakesh & Thulkar, Sanjay & Mallick, Saumyaranjan. (2019). Induction Therapy with Novel Agents and Autologous Stem Cell Transplant Overcomes the Adverse Impact of Renal Impairment in Multiple Myeloma. Clinical Hematology International. 1. 10.2991/chi.d.190805.003.
Tripathy, Sarthak & Shamim, Shamim & Chellapuram Santosh Kumar & Barwad, Adarsh & Rastogi, Sameer. (2019). Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of Kidney With Inferior Vena Cava Thrombus: Findings on 18F-FDG PET/CT. Clinical Nuclear Medicine. 45. 1. 10.1097/RLU.0000000000002865

Certifications & Memberships

Awards and Achievements

Prathibha awards for securing outstanding marks in class 11th and 12th
Graduated MBBS degree in FIRST CLASS
Secured 1st place in State level and Regional level Psychiatry Quiz Competition during MBBS
Secured 1st place at National Level Medical Oncology quiz Competition ICON-2018
Poster Selected for International Myeloma Conference(IMWG): 2019,Boston USA.
Best Orator: TYSA 2020 National Conference
1st Runner up: TYSA 2020 National Conference
Secured gold Medal In DM Medical Oncology AIIMS

Doctors | Star Hospitals

Dr. Santosh Kumar Chellapuram

Qualifications

Experience

Field of Expertise

Research & Publications

Certifications & Memberships